[{"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots within expiry.", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "Dexmedetomidine HCl all strengths, all dosage forms and all packaging, Rx  Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0846-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA060711"], "brand_name": ["PENICILLIN V POTASSIUM"], "generic_name": ["PENICILLIN V POTASSIUM"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-1172", "0093-1174", "0093-4125", "0093-4127"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PENICILLIN V POTASSIUM"], "rxcui": ["834040", "834046", "834061", "834102"], "spl_id": ["165377dd-4272-4194-9d0b-36d213498f26"], "spl_set_id": ["3111ca84-6f8e-45ea-91a1-9cb99c63607e"], "package_ndc": ["0093-1172-01", "0093-1172-10", "0093-1174-01", "0093-1174-10", "0093-4125-73", "0093-4125-74", "0093-4127-73", "0093-4127-74"], "is_original_packager": [true], "upc": ["0300934127737", "0300934125733", "0300931172013"], "unii": ["146T0TU1JB"]}, "product_type": "Drugs", "event_id": "78641", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico.", "recall_number": "D-0108-2018", "product_description": "Penicillin V Potassium for Oral Solution, USP, 125 mg (200,000 U) per 5 mL, 100 mL (when mixed) bottle, Rx only, Manufactured In Canada By: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454; NDC 0093-4125-73.", "product_quantity": "42,384 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: high out of specification test results obtained for individual and total impurities.", "recall_initiation_date": "20171128", "center_classification_date": "20171213", "termination_date": "20180703", "report_date": "20171220", "code_info": "Lot # 35433115A, Exp 01/18"}, {"status": "Terminated", "city": "Roseville", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "76511", "recalling_firm": "Organic Herbal Supply", "address_1": "8303 Sierra College Blvd Ste 128", "address_2": "N/A", "postal_code": "95661-9420", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide through Amazon.com online and direct from firm's website www.xtrahrd.com and www.Zrect.com", "recall_number": "D-0646-2017", "product_description": "XtraHRD Natural Male Enhancement Capsules, Herbal Dietary Supplement, 500 mg capsules, 2, 4 and 10 count boxes, Made in Malaysia, Distributed by Naturally Hard Supplements, Reno, NV 89503, UPC 680474228768", "product_quantity": "100,000 to 150,000 capsules", "reason_for_recall": "Marketed without an Approved NDA/ANDA: Product contains N-desmethyl tadalafil an analogue to tadalafil which is an active pharmaceutical ingredient in a FDA approved drug used to treat erectile dysfunction (ED).", "recall_initiation_date": "20170216", "center_classification_date": "20170405", "termination_date": "20170913", "report_date": "20170412", "code_info": "All lots"}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78364", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico.", "recall_number": "D-0069-2018", "product_description": "Dutasteride and Tamsulosin HCl Capsules, 0.5 mg/ 0.4 mg, packaged in a) 30-count bottle (NDC 0591-3771-30), b) 90-count bottle (NDC 0591-3771-19), Rx only, Manufactured by: Actavis Laboratories FL, Inc. Fort Lauderdale, FL 33314 USA; Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA.", "product_quantity": "140,993 bottles", "reason_for_recall": "Failed dissolution specifications; all lots within expiry are being recalled due to out of specification dissolution results.", "recall_initiation_date": "20171025", "center_classification_date": "20171102", "termination_date": "20180502", "report_date": "20171108", "code_info": "Lot Numbers: a) 1089376A, 1089382A, 1095210M, 1117768M, 1117769A, Exp. 11/17; 1128452A, 1128453A, 1137658A, 1154207A, 1156087A, Exp. 03/18; b) 1089379A, 1091533M, 1125206A, Exp. 11/17; 1128456A, 1147665A,  1154208A,  1156088A, Exp. 03/18."}, {"status": "Terminated", "city": "Caguas", "state": "PR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76020", "recalling_firm": "Mylan LLC.", "address_1": "Road #156, Km. 58.8, Lot 24B", "address_2": "N/A", "postal_code": "00725", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0443-2017", "product_description": "Temozolomide Capsules, 180 mg, packaged in a) 5-count bottles (NDC 0378-5264-98), b) 14-count bottles (NDC 0378-5264-14), Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 USA.", "product_quantity": "a) 300 bottles (lot 2006915); b) 156 bottles (lot 2006914)", "reason_for_recall": "Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.", "recall_initiation_date": "20161220", "center_classification_date": "20170125", "termination_date": "20180125", "report_date": "20170201", "code_info": "LOT #: a) 2006915, Exp 02/18; b) 2006914, Exp 02/18"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77822", "recalling_firm": "Akorn Inc", "address_1": "1925 W Field Ct", "address_2": "N/A", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1090-2017", "product_description": "Halyard 24-Hour Oral Care Kit q4, contains 2x15 mL Unit Dose Cups 0.12% Chlorhexidine Gluconate Oral Rinse.  Manufactured by Halyard Health Inc., 5405 Windward Parkway, Alpharetta, GA 30004. Distributed by Halyard Sales, LLC Alpharetta, GA 30004. REF # 97014", "product_quantity": "101,952 15 mL unit dose cups", "reason_for_recall": "Crystallization with subpotent out of  specification assay results for chlorhexidine.", "recall_initiation_date": "20170712", "center_classification_date": "20170814", "termination_date": "20180619", "report_date": "20170823", "code_info": "Lots: 0202635072, 0202635073, EXP 06-2018; 0202630205, 0202630206, EXP 07-2018; 0202630203, 0202630204,  0202642217, 0202642218, 0202642219, 0202647410, 0202647411, EXP 08-2018; 0202647409,  0202647412, 0202653431, 0202653432, EXP 09-2018."}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0297-2017", "product_description": "Testosterone Cypionate in Sesame, 100 mg/mL, (5 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "166 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.    Known lot codes (Exp Date): 07152016A (01/11/2017), 08182016A (02/14/2017), 09282016J (03/27/2017)."}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77770", "recalling_firm": "SCA Pharmaceuticals", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1020-2017", "product_description": "NORepinephrine 4 mg in 0.9% Sodium Chloride 250 mL from Stock, Rx only, SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR 72205 --- NDC# 70004-0771-40", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; product has the potential to leak.", "recall_initiation_date": "20170714", "center_classification_date": "20170726", "termination_date": "20190501", "report_date": "20170802", "code_info": "Lots: 20170502@36 BUD: 7/31/2017; 20170512@1 BUD: 8/10/2017; 20170504@13 BUD: 8/2/2017; 20170504@18 BUD: 8/2/2017"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0269-2017", "product_description": "Lipo-C (Methionine 25 mg/Inositol 50 mg/Choline Chloride 50 mg/Carnitine (L) 100 mg/Methylcobalamin 1 mg/Thiamine HCL 50 mg/Rivoflavin-5-Phosphate Sod 5 mg/Niacinamide 50 mg/Dexpanthenol 5 mg/Pyridoxine HCL 1.25 mg/Lidocaine HCL 10 mg/mL), (30 ML). Compounded by Tri-Coast Pharmacy", "product_quantity": "69 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.     Known lot codes (Exp Date): 07282016B (12/31/2016), 08242016B (12/31/2016)"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0298-2017", "product_description": "Testosterone Cypionate in Sesame, 150 mg/mL, (5 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "400 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.    Known lot codes (Exp Date): 05122016B (11/18/2016), 08012016C (01/28/2017), 09262016D (03/25/2017)."}, {"country": "United States", "city": "Morristown", "address_1": "36 Columbia Rd", "reason_for_recall": "Labeling: Incorrect/Undeclared Excipients: Firm is recalling A+D Diaper Rash Cream due to a labeling claim issue.", "address_2": "", "product_quantity": "a) 468,576 (1.5g); b) 203868 (3 oz) and c) 802,620 (4 oz)", "code_info": "a) Lot #: CV0068D, Exp. 12/31/2018; CV008N6, Exp. 2/28/2019; CV008N7, Exp. 3/31/2019; CV00BJA, Exp. 6/30/2019; CV00D0V and CV00DM4, Exp.8/31/2019.    b) Lot #: CV0068G, Exp. 12/31/2018; CV008N9, Exp. 3/31/2019; CV008N8, Exp. 4/30/2019; CV00D0U, Exp. 8/31/2019 and CV00G4U, Exp.10/31/2019.    c) Lot #: CV0068M, Exp. 12/31/2018; CV0068K, Exp.1/31/2019; CV008N5, Exp.  2/28/2019; CV008NC and CV008NE, Exp. 3/31/2019; CV008ND, CV008NB and CV008NA, Exp.4/30/2019; CV008NH, CV008NG and CV008NJ, Exp. 05/31/2019; CV00BJC, Exp.6/30/2019; CV00BJB, CV00BJE, CV00BJD, CV00BXB, CV00BXA and CV00BX9, Exp.7/31/2019; CV00D7H, CV00D7G, CV00D7E and CV00D7J, Exp. 8/31/2019; CV00E5T, CV00E5S and CV00E5R, Exp. 9/30/19; CV00G69 and CV00G6B, Exp.10/31/2019.", "center_classification_date": "20170321", "distribution_pattern": "US Nationwid, Puerto Rico, and Iceland", "state": "NJ", "product_description": "A+D Diaper Rash Cream with Dimethicone 1% and Zinc Oxide 10%, Packaged in a) 1.5 oz (42.5g) ( UPC 041100811288), b) 3 oz 85g (UPC 041100811301), c) 4 oz (113g) (UPC 041100811325), Distributed by: Bayer Healthcare LLC, Whippany, NJ 07981", "report_date": "20170329", "classification": "Class III", "openfda": {}, "recalling_firm": "Bayer HealthCare Pharmaceuticals, Inc.", "recall_number": "D-0604-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76585", "termination_date": "20180103", "more_code_info": "", "recall_initiation_date": "20170221", "postal_code": "07960-4526", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091226"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-3950", "0378-3951", "0378-3952", "0378-3953"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["259255", "617310", "617311", "617312"], "spl_id": ["c94bf799-ec3d-4644-b1a2-3c7b3f612e19"], "spl_set_id": ["d0a0feb6-84f0-4693-a11f-eb4f7ae0a87d"], "package_ndc": ["0378-3950-77", "0378-3950-05", "0378-3950-09", "0378-3950-07", "0378-3951-77", "0378-3951-05", "0378-3951-09", "0378-3951-07", "0378-3952-77", "0378-3952-05", "0378-3952-09", "0378-3952-07", "0378-3953-77", "0378-3953-05", "0378-3953-09", "0378-3953-07"], "is_original_packager": [true], "upc": ["0303783953779", "0303783952772", "0303783950778", "0303783951775"], "unii": ["48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "76750", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0621-2017", "product_description": "Atorvastatin Calcium Tablets, 80 mg*, packaged in a) 90-count bottles (NDC 0378-3953-09) and b) 500-count bottles (NDC 0378-3953-07), Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV  26505 U.S.A.", "product_quantity": "452,269 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.", "recall_initiation_date": "20170320", "center_classification_date": "20170328", "termination_date": "20180126", "report_date": "20170405", "code_info": "Lot #: a) 3073782, 3073783, Exp 02/18; 3074915, 3074916, 3074917, Exp 03/18; 3074918, 3075572, Exp 04/18; 3075573, 3075574, Exp 05/18; 2007226, 3075894, Exp 06/18; 2007344, 2007345, 2007346, Exp 08/18; 2007451, 2007452, 2007453, 2007454, Exp 09/18; b) 3070840, Exp 10/17; 3073781, 3074911, Exp 02/18; 3074912, 3074913, 3074914, Exp 03/18; 3075570, 3075571, Exp 04/18; 3075892, Exp 05/18; 3075893, Exp 06/18; 2007341, 2007342, 2007343, 2007347, Exp 08/18; 2007456, Exp 10/18", "more_code_info": ""}, {"country": "United States", "city": "Little Rock", "address_1": "8821 Knoedl Ct", "reason_for_recall": "Lack of assurance of sterility: Product bags leaking at seam.", "address_2": "", "product_quantity": "80 bags", "code_info": "LOT # 20170508@57, Use By: 08/06/17", "center_classification_date": "20170531", "distribution_pattern": "Nationwide in the USA", "state": "AR", "product_description": "morphine sulfate in 0.9% Sodium Chloride injectable, 1 mg per mL, Total Volume 100 mL, Single Dose Container bag, (Total morphine Dose 100 mg/ 100mL), Preservative Free (Contains Sulfites), Rx only, SCA Pharmaceuticals, 8821 Knoedl Ct, Little Rock, AR  72205, NDC 70004-0100-32.", "report_date": "20170607", "classification": "Class II", "openfda": {}, "recalling_firm": "SCA Pharmaceuticals", "recall_number": "D-0870-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77314", "termination_date": "20180329", "more_code_info": "", "recall_initiation_date": "20170518", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075880"], "brand_name": ["PREMASOL - SULFITE-FREE (AMINO ACID)"], "generic_name": ["LEUCINE, LYSINE, ISOLEUCINE, VALINE, HISTIDINE, PHENYLALANINE, THREONINE, METHIONINE, TRYPTOPHAN, TYROSINE, N-ACETYL-TYROSINE, ARGININE, PROLINE, ALANINE, GLUTAMIC ACIDE, SERINE, GLYCINE, ASPARTIC ACID, TAURINE, CYSTEINE HYDROCHLORIDE"], "manufacturer_name": ["Baxter Healthcare Company"], "product_ndc": ["0338-1130", "0338-1131"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["ALANINE", "ARGININE", "ASPARTIC ACID", "CYSTEINE HYDROCHLORIDE", "GLUTAMIC ACID", "GLYCINE", "HISTIDINE", "ISOLEUCINE", "LEUCINE", "LYSINE ACETATE", "METHIONINE", "PHENYLALANINE", "PROLINE", "SERINE", "TAURINE", "THREONINE", "TRYPTOPHAN", "TYROSINE", "VALINE"], "rxcui": ["801395", "801398", "801403", "801405"], "spl_id": ["4083b5c8-ad5f-43f6-ab19-3c87acb2883f"], "spl_set_id": ["9afdcc3e-0d06-47f4-86ca-40da48b2b02b"], "package_ndc": ["0338-1130-03", "0338-1130-04", "0338-1130-06", "0338-1131-03"], "is_original_packager": [true], "nui": ["N0000175780", "M0000922"], "pharm_class_epc": ["Amino Acid [EPC]"], "pharm_class_cs": ["Amino Acids [CS]"], "unii": ["OF5P57N2ZX", "94ZLA3W45F", "30KYC7MIAI", "ZT934N0X4W", "3KX376GY7L", "TE7660XO1C", "4QD397987E", "04Y7590D77", "GMW67QNF9C", "TTL6G7LIWZ", "AE28F7PNPL", "47E5O17Y3R", "9DLQ4CIU6V", "452VLY9402", "1EQV5MLY3D", "2ZD004190S", "8DUH1N11BX", "42HK56048U", "HG18B9YRS7"]}, "product_type": "Drugs", "event_id": "75835", "recalling_firm": "Baxter Healthcare Corporation", "address_1": "1 Baxter Pkwy", "address_2": "", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "US", "recall_number": "D-0425-2017", "product_description": "10% Premasol sulfite-free (Amino Acid) Injection, 2000 mL bulk package, Rx only,  Baxter Healthcare Corporation, Clintec Nutrition Division, Deerfield, IL 60015 USA, NDC 0338-1130-06", "product_quantity": "3,528 eaches", "reason_for_recall": "Discoloration: there were customer reports of yellow discolored solution. The yellow coloration is the result of oxidation of the amino acid tryptophan due to a damaged overpouch.", "recall_initiation_date": "20161206", "center_classification_date": "20170109", "termination_date": "20180326", "report_date": "20170118", "code_info": "Lot #:  P333617, Exp 4/30/17", "more_code_info": ""}, {"status": "Terminated", "city": "Chandler", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78227", "recalling_firm": "Banner Pharmacy Services, LLC", "address_1": "7300 W Detroit St", "address_2": "N/A", "postal_code": "85226-2410", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the US", "recall_number": "D-0017-2018", "product_description": "fentaNYL citrate 1000 mcg (10 mcg/mL) 100 mL Cassette in 0.9% Sodium Chloride, Rx Only, Banner Health Compounding Pharmacy 7300 W Detroit St Chandler, AZ 85226, NDC 7025011001", "product_quantity": "9030 cassetts", "reason_for_recall": "Lack of Assurance of Sterility.", "recall_initiation_date": "20171010", "center_classification_date": "20171023", "termination_date": "20180809", "report_date": "20171101", "code_info": "Lot #:  041317S1, Exp 10/10/2017; 041817S1, Exp 10/15/2017;  042017S1, 10/17/2017;  042517S1, 10/22/2017;  042717S1, Exp 10/24/2017;  050217S1, Exp 10/29/2017; 050417S2, Exp 10/31/2017;  050917S1, 11/5/2017; 051117S1, 051117S4,11/7/2017;  051617S1, 11/12/2017;  051817S1, Exp 11/14/2017;  052317S1, Exp 11/19/2017;  053017S1, Exp 11/26/2017;  060617S1, Exp 12/3/2017; 060917S1, Exp 12/6/2017; 061317S1, Exp 12/10/2017;  061517S2,  Exp 12/12/2017; 062017S1,  Exp 12/17/2017; 062217S1, Exp 12/19/2017; 062717S1, Exp 12/24/2017; 62817S1, Exp 12/25/2017;  070417S1, Exp 12/31/2017; 070517S1, Exp 1/1/2018; 071317S1, Exp 1/7/2018; 071817S2,  Exp 1/14/2018; 072017S1,Exp 1/16/2018;  72517S2, Exp 1/21/2018;  080817S1,  Exp 2/4/2018; 080917S1, Exp 2/5/2018; 081617S1, Exp 2/12/2018;  081717S1, Exp 2/13/2018."}, {"status": "Terminated", "city": "Vasco Da Gama", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA077917"], "brand_name": ["PRAVASTATIN SODIUM"], "generic_name": ["PRAVASTATIN SODIUM"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-485", "68180-486", "68180-487", "68180-488"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PRAVASTATIN SODIUM"], "rxcui": ["904458", "904467", "904475", "904481"], "spl_id": ["a173dd76-57cb-4066-a51f-26adfb79e861"], "spl_set_id": ["1123d56c-16f0-4f81-b56f-67b1f343ae1e"], "package_ndc": ["68180-485-03", "68180-485-09", "68180-485-02", "68180-486-09", "68180-486-02", "68180-486-03", "68180-487-09", "68180-487-02", "68180-487-03", "68180-488-09", "68180-488-02", "68180-488-03"], "is_original_packager": [true], "upc": ["0368180487098"], "unii": ["3M8608UQ61"]}, "product_type": "Drugs", "event_id": "78566", "recalling_firm": "Lupin Limited", "address_1": "15 - B I Phase 1a", "address_2": "I D C Verna Industrial Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States, including Puerto Rico.", "recall_number": "D-0092-2018", "product_description": "Pravastatin Sodium USP, tablets, 40 mg, 90-count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, NDC 68180-487-09", "product_quantity": "N/A", "reason_for_recall": "Presence of foreign tablets/capsules: This product lot is being recalled due to a pharmacy complaint where one Duloxetine Delayed Release Capsule, 30mg was found in a Pravastatin Sodium Tablets USP, 40mg bottle.", "recall_initiation_date": "20171117", "center_classification_date": "20171121", "termination_date": "20190315", "report_date": "20171129", "code_info": "Lot # G702459, Exp 2/20"}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots within expiry.", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "Sodium Citrate all strengths, all dosage forms and all packaging, Rx  Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0851-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0295-2017", "product_description": "Slim Shot (Methionine (L) 25mg/Inositol 50mg/Choline Chloride 50mg/Methylcobalamin 1 mg/Pyridoxine HCL 2.2mg/ml), (30 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "127 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.    Known lot codes (Exp Date): 06292016A (12/26/2016), 08102016C (01/31/2017), 10262016C (02/28/2017)."}, {"status": "Terminated", "city": "South San Francisco", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "78088", "recalling_firm": "Genentech, Inc.", "address_1": "1 Dna Way", "address_2": "N/A", "postal_code": "94080-4990", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1175-2017", "product_description": "Activase (alteplase), 100 mg (58 million IU), Lyophilized vial, packaged with 1 single-dose 100ml vial of sterile water for Injection USP and one transfer device.  Manufactured by: Genentech, Inc. 1 DNA Way, South San Francisco, CA 84080-4990. NDC: 50242-0085-27", "product_quantity": "16,882", "reason_for_recall": "Non-Sterility:presence of cracked or chipped glass at the neck of Sterile Water for Injection vials.", "recall_initiation_date": "20170905", "center_classification_date": "20171201", "termination_date": "20190111", "report_date": "20170927", "code_info": "Lot# 3128243, 3141239, EXP. 9/30/2018; 3166728, EXP. 2/28/2019.", "more_code_info": ""}, {"status": "Terminated", "city": "Waco", "state": "TX", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA022184"], "brand_name": ["LUMIGAN"], "generic_name": ["BIMATOPROST"], "manufacturer_name": ["Allergan, Inc."], "product_ndc": ["0023-3205"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["BIMATOPROST"], "rxcui": ["1009339", "1009341"], "spl_id": ["719ecc42-4162-497f-ad35-9e36b8eef0d5"], "spl_set_id": ["a5e67c75-db88-4372-bb07-c8dd15c97631"], "package_ndc": ["0023-3205-02", "0023-3205-03", "0023-3205-05", "0023-3205-08"], "is_original_packager": [true], "nui": ["N0000175454", "M0017805"], "pharm_class_epc": ["Prostaglandin Analog [EPC]"], "pharm_class_cs": ["Prostaglandins [CS]"], "unii": ["QXS94885MZ"]}, "product_type": "Drugs", "event_id": "78325", "recalling_firm": "Allergan Sales, LLC", "address_1": "8301 Mars Dr", "address_2": "N/A", "postal_code": "76712-6578", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and  Barbados, Curacao, Dominican Republic, Guyana, Jamaica, and Trinidad and Tobago.", "recall_number": "D-0078-2018", "product_description": "Lumigan (bimatoprost ophthalmic solution) 0.01%, 2.5 mL bottle,  Rx only, Allergan, Irvine, CA 92612. NDC# 0023-3205-03", "product_quantity": "153,616 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications.", "recall_initiation_date": "20171019", "center_classification_date": "20171113", "termination_date": "20191030", "report_date": "20171122", "code_info": "Lot #: 92575 Exp. JUN-2018"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0561-2017", "product_description": "JESSNERS PEEL (salicylic Acid 14% rescorcinol 14%, Lactic acid 14%), Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "Chicago", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077789"], "brand_name": ["CHLORHEXIDINE GLUCONATE"], "generic_name": ["CHLORHEXIDINE GLUCONATE"], "manufacturer_name": ["Xttrium Laboratories, Inc."], "product_ndc": ["0116-2001"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORHEXIDINE GLUCONATE"], "rxcui": ["834127"], "spl_id": ["0cf3f53a-1fe5-92d7-e063-6394a90a9e9d"], "spl_set_id": ["34d15e72-8770-49dc-a514-d44ae4468a1e"], "package_ndc": ["0116-2001-16", "0116-2001-04", "0116-2001-15", "0116-2001-05", "0116-2001-06", "0116-2001-07"], "is_original_packager": [true], "upc": ["0301162001158"], "unii": ["MOR84MUD8E"]}, "product_type": "Drugs", "event_id": "77443", "recalling_firm": "Xttrium Laboratories Inc", "address_1": "415 W Pershing Rd", "address_2": "N/A", "postal_code": "60609-2788", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Natiowide", "recall_number": "D-0938-2017", "product_description": "Chlorhexidine Gluconate 0.12% Oral Rinse, USP, 1 Pint (473 ml), Rx Only,  Distributed by: Xttrium Laboratories, Inc., Mount Prospect, IL 60056, NDC 0116-2001-16", "product_quantity": "36,720 16 oz. glass bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20170601", "center_classification_date": "20170702", "termination_date": "20180219", "report_date": "20170712", "code_info": "1999CHG16MC-Lot number 704-201 (full lot # 704-1999-201), Exp 03/20  1999CHG16MC-Lot number 705-208 (full lot # 705-1999-208), Exp 04/20"}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots within expiry", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "Penicillin G Potassium all strengths, all dosage forms and all packaging, Rx  Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0819-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0286-2017", "product_description": "Quad Mix, Alprostadil/Phentolamine/Papaverine/Atropine 18mcg/1mg/1.8mg/0.02mg/ml, (1 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "17 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.     Known lot codes (Exp Date): 07252016E (09/04/2016), 09142016A (09/29/2016), 07192016E (09/01/2016), 07052016B (08/04/2016)."}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots within expiry", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "Ephedrine Sulfate all strengths, all dosage forms and all packaging, Rx  Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0826-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0411-2017", "product_description": "Trimix with Atropine Injectable 30 mg/3 mg/60 mcg/0.2 mg/mL, 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "1 vial", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known lot code: 04112016@6."}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0568-2017", "product_description": "QUAD PEEL (Sal Acid 2%, TCA 7%, Phenol 7%, Retinoic acid 0.4%), Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0590-2017", "product_description": "MELATONIN 1.5MG SPRAY, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0382-2017", "product_description": "Nandrolone Decanote (H), 200 mg/mL Injectable, 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "526 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known lot code: 04112016@16, 04282016@3, 05202016@6, 06132016@4, 07052016@1, 07272016@7."}, {"status": "Terminated", "city": "Brockton", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78376", "recalling_firm": "Ace Surgical Supply Co., Inc.", "address_1": "1034 Pearl St", "address_2": "N/A", "postal_code": "02301-5411", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States.", "recall_number": "D-0071-2018", "product_description": "Succinylcholine 20 MG/ML INJ (QUELICIN), 10 ML Vials, Rx only, Distributed by: ACE Surgical Co., Inc., Brockton, MA", "product_quantity": "200 vials (25 mislabeled vials)", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date;  incorrect expiration date on the labeling of the outer poly bag", "recall_initiation_date": "20171024", "center_classification_date": "20171107", "termination_date": "20180320", "report_date": "20171115", "code_info": "Lot # 64340EV, exp 07/2018  ACE ITEM # 1671018"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0401-2017", "product_description": "Testosterone Cypionate in Grapeseed Oil Injectable, 20 mg/mL, 5 mL vial, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "146 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known lot code: 04142016@5, 04292016@5, 05022016@6, 07062016@7."}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0355-2017", "product_description": "DMSO (Dimethyl Sulfoxide) with Lidocaine 50%/0.5% mL Solution, 50 mL bottle, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "438 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known lot code: 04132016@69, 04272016@9, 05142016@13, 06162016@129, 07052016@12, 07292016@2."}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "2 vials", "code_info": "Lot # t12-22-2016@102, Exp 6/18/2017", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "TRI MIX 10/15/1 5ML MDV MCG/MG/MG/ML INJ, Injection, 10mcg/15mg/1mg/mL, Rx only, 5 mL Glass/ Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0735-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0526-2017", "product_description": "TACROLIMUS 0.1% Ointment and TACROLIMUS 0.1%/KETOCONAZOLE 2%, Rx only, Synergy Rx, 4901 Morena Blvd #504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0580-2017", "product_description": "DICLOFENAC 3% and 5% LIP BALM and DICLOFENAC 5% SPF 30 LIP BALM, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "Qinhuangdao", "state": "N/A", "country": "China", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76890", "recalling_firm": "Qinhuangdao Zizhu Pharmaceutical, Co.", "address_1": "No 10, Longhai Road", "address_2": "Economic &amp; Technological Development Zon", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product distributed to NY, TX, SC, CO, MN and NJ", "recall_number": "D-0660-2017", "product_description": "Levonorgestrel Non-Micronized, USP, Bulk, Rx only, For Prescription Compounding, Manufactured by Qinhuangdao Zizhu Pharmaceutical Co., Ltd., Qinhuangdao 066004, China  (NDC 44132-012-01),", "product_quantity": "N/A", "reason_for_recall": "cGMP Deviations; lack of quality assurance.", "recall_initiation_date": "20170324", "center_classification_date": "20170411", "termination_date": "20180703", "report_date": "20170419", "code_info": "Batch 70001602009, 2/21/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77780", "recalling_firm": "Cantrell Drug Company", "address_1": "7321 Cantrell Rd", "address_2": "N/A", "postal_code": "72207-4144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the US", "recall_number": "D-1063-2017", "product_description": "Ephedrine Sulfate Injection Solution 1 mL,  50 mg/1 mL (50 mg/mL) Single-Dose Syringe,  Rx Only, Cantrell Drug Company 7321 Cantrell Rd Little Rock, AR 72207 877-666-5222,  NDC 52533-258-45", "product_quantity": "7656 syringes", "reason_for_recall": "Lack of Sterility Assurance.", "recall_initiation_date": "20170714", "center_classification_date": "20170809", "termination_date": "20200916", "report_date": "20170816", "code_info": "Lot #: 10099, BUD: 7/27/2017; 10127, BUD: 8/1/2017; 10208, BUD: 8/10/2017; 10254, BUD: 8/15/2017; 10278, BUD: 8/17/2017; 10303, BUD: 8/21/2017; 10371, BUD: 9/3/2017; 10457, BUD: 9/17/2017"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "76284", "recalling_firm": "Hospira Inc., A Pfizer Company", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0638-2017", "product_description": "Vancomycin Hydrochloride for Injection, USP, 10 grams, Pharmacy Bulk Package - Not For Direct Infusion, For Intravenous Use, packaged in 100 mL glass vial, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-6510-01", "product_quantity": "30,880 vials", "reason_for_recall": "Presence of Particulate Matter: A hair was found stuck to the stopper of inside a single vial. The hair came in contact with the reconstituted drug product.", "recall_initiation_date": "20170124", "center_classification_date": "20170405", "termination_date": "20180426", "report_date": "20170412", "code_info": "Lot # 591053A, Exp 11/1/2017"}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA091133"], "brand_name": ["BENZONATATE"], "generic_name": ["BENZONATATE"], "manufacturer_name": ["Strides Pharma Science Limited"], "product_ndc": ["64380-712", "64380-713"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BENZONATATE"], "rxcui": ["197397", "283417"], "spl_id": ["21343425-d42f-4a46-ba47-30cedc9fe876"], "spl_set_id": ["89f5d18e-5ef4-42a3-bc6f-abf4f308462b"], "package_ndc": ["64380-712-06", "64380-712-07", "64380-713-06", "64380-713-07"], "is_original_packager": [true], "upc": ["0364380712077", "0364380712060", "0364380713074"], "nui": ["N0000009010", "N0000175796"], "pharm_class_pe": ["Decreased Tracheobronchial Stretch Receptor Activity [PE]"], "pharm_class_epc": ["Non-narcotic Antitussive [EPC]"], "unii": ["5P4DHS6ENR"]}, "product_type": "Drugs", "event_id": "77311", "recalling_firm": "Strides Pharma INC", "address_1": "2 Tower Center Blvd Ste 1102", "address_2": "", "postal_code": "08816-1100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0858-2017", "product_description": "Benzonatate capsules, 200 mg, 100-count bottle, Rx only, Manufactured by: Strides Shasun Limited Bangaluru -560076 India, Distributed by Strides Pharma Inc East Brunswick, NJ 08816, NDC 64380-713-06", "product_quantity": "127,517 bottles", "reason_for_recall": "Failed Stability Specifications: Out of Specification results obtained for preservative Methylparaben content.", "recall_initiation_date": "20170509", "center_classification_date": "20170523", "termination_date": "20171222", "report_date": "20170531", "code_info": "Lot #: 7225075, 7225076, 7225077, 7225078, 7225079, 7225080 Exp 7/2017; 7225180, 7225181, 7225322, 7225323, Exp 8/2017; 7225649A, 7225650A , 7225651A , 7225652A, 7225653A, 7225654A, Exp 9/2017", "more_code_info": ""}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "2 vials", "code_info": "Lot # t02-06-2017@102, Exp 4/30/2017; t02-16-2017@106, Exp 4/30/2017.", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "HYDROXO-B12 30ML PBF MDV (CALIF) 1MG/ML INJ, Injection, 1mg/mL, Rx only, 30 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0726-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78063", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide.", "recall_number": "D-0038-2018", "product_description": "Oxytocin 20 units added to 1000 mL Lactated Ringer's Injection USP in 1000 mL bag, Rx Only, Compounded by PharMEDium Services, LLC. 12620 W. Airport Blvd. #130 Sugar Land, TX 77478, NDC# 71019-241-06", "product_quantity": "Unknown", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20170901", "center_classification_date": "20171025", "termination_date": "20200124", "report_date": "20171101", "code_info": "All unexpired lots."}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75640", "recalling_firm": "VistaPharm, Inc.", "address_1": "7265 Ulmerton Rd", "address_2": "N/A", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Domestic: AL, AZ, CA, CO, CT, FL, GA, HI, IA, IL, IN, KS, KY, LA, MA, MI, MN, MO, MS, NC, NE, NH, NJ, NM, NY, OH, OK, OR, PA, TN, TX, UT, VA, WA WI, & WV.", "recall_number": "D-0469-2017", "product_description": "Potassium Chloride Oral Solution,  USP, 10%, 20 mEq per 15 mL, packaged in 15 mL unit dose cups (NDC 66689-047-01), 50 unit dose cups per case (NDC 66689-047-50), Rx only, Xact Dose, Manufactured by VistaPharm, Largo, FL  33771.", "product_quantity": "13,609 cases", "reason_for_recall": "Defective Container: Leakage of unit dose cups that may occur at the seal.", "recall_initiation_date": "20170118", "center_classification_date": "20170206", "report_date": "20170215", "code_info": "Lot #'s: 437600, Exp 07/17; 447100, Exp 10/17"}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots within expiry.", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "Fentanyl Citrate and Bupivacaine HCl  all strengths, all dosage forms and all packaging, Rx  Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0853-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0372-2017", "product_description": "MIC/B-COMP+CARN+LIDO, 15 mg/30 mg/30 mg/85 mg/20 mg/mL Injectable, 30 mL vial, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "1716 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known lot code: 03302016@9, 04072016@15, 05022016@14, 05052016@5, 05162016@16, 06012016@11, 06092016@30, 06152016@15, 06212016@2, 07152016@8, 08042016@21."}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75650", "recalling_firm": "VistaPharm, Inc.", "address_1": "7265 Ulmerton Rd", "address_2": "N/A", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0464-2017", "product_description": "Oxycodone Hydrochloride Oral Solution, USP 5 mg/5 mL, a). 5 mL, 50 unit dose cups of 5 mL per case (NDC No. 66689-401-50), b). 500 mL, 12 bottles per case (NDC No. 66689-403-16), Rx only, Manufactured by VistaPharm, Largo, FL 33771.", "product_quantity": "42,776 unit dose cups and 17,403 bottles", "reason_for_recall": "CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.", "recall_initiation_date": "20170118", "center_classification_date": "20170202", "termination_date": "20210826", "report_date": "20170208", "code_info": "a). Lot No. 427900, 426700 (Exp. 11/17), 424800, 423600 (Exp. 10/17), 420800 (09/17), 416300 (08/17), 407700, 407300 (Exp. 06/17), 405900, 403900 (Exp. 05/17)   b). Lot No. 426900 (Exp. 11/17), 404700 (Exp. 05/17), 390200 (Exp. 02/17)", "more_code_info": ""}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0386-2017", "product_description": "Sermorelin Acetate 15 mg Injectable Kit., Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "568  kits (number of vials per kit vary by prescription)", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known kit lot code: 05182016@173, 07052016@148, 09062016@114.  Known vial lot code: 04252016@165, 06102016@56, 08262016@42."}, {"country": "United States", "city": "Saint Paul", "address_1": "2400 Pilot Knob Rd", "reason_for_recall": "cGMP Deviations: lack of quality assurance at the API manufacturer.", "address_2": "", "product_quantity": "15283 grams", "code_info": "Lot #, Expiration Date:   a) 1 G bottle: 16D08-U02-030005,  Exp. 3/6/2018; 16F23-U05-033657, Exp. 5/26/2018; 17C02-U02-035889, Exp. 1/19/2019.  b) 5 G bottle: 16D08-U02-030004, 16D08-U02-032486, Exp. 3/6/2018; 16F23-U05-033656, 16F23-U05-035093, Exp. 5/26/2018; 17C02-U02-035890,  Exp. 1/19/2019.  c) 25 G bottle: 16D08-U02-030003, 16D08-U02-032475, Exp. 3/6/2018; 16F23-U05-033655, 16F23-U05-035092, Exp. 5/26/2018; 17C02-U02-035887, Exp.  1/19/2019.  d) 100 G bottle: 16D08-U02-030002, 16D08-U02-032474, Exp. 3/6/2018; 16F23-U05-031158,16F23-U05-033654, 16F23-U05-035091,16G18-F002,  Exp. 5/26/2018; 17C02-U02-035888, Exp. 1/19/2019.", "center_classification_date": "20170519", "distribution_pattern": "Nationwide in US and PR and Australia", "state": "MN", "product_description": "Estriol, For Prescription Compounding, packaged in a) 1 G bottle (NDC: 51552-1392-1), b) 5 G bottle (NDC: 51552-1392-2),  c) 25 G bottle (NDC: 51552-1392-3), d) 100 G bottle (NDC: 51552-1392-5), RX only, Distributed by Fagron, Inc. 2400 Pilot Knob Rd, St. Paul, MN 55120 Tel. 1-(800) 423-6967     Also packaged as: Estriol USP Micronized, For prescription compounding, packaged in a 100 G bottle (NDC 52372-9292-01),  Rx only, Distributed by FREEDOM, 801 W. New Orleans St. Broken Arrow, OK 74011", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Fagron, Inc", "recall_number": "D-0791-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77060", "termination_date": "20190701", "more_code_info": "", "recall_initiation_date": "20170406", "postal_code": "55120-1118", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78320", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the United States", "recall_number": "D-0061-2018", "product_description": "HYDROmorphone HCl 20 mcg / mL BUPIvacaine HCl 0.075% in 0.9% Sodium Chloride 50 mL (HYDROmorphone Total Dose 1000 mcg) Rx Only, SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR 72205, NDC 70004-0331-22", "product_quantity": "60 bags", "reason_for_recall": "Lack Of Assurance Of Sterility.", "recall_initiation_date": "20171019", "center_classification_date": "20171102", "termination_date": "20190501", "report_date": "20171108", "code_info": "Lot: 20170816@65 BUD: 10/30/2017"}, {"status": "Terminated", "city": "Newark", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "78151", "recalling_firm": "Gadget Island, Inc", "address_1": "5889 Central Ave", "address_2": "N/A", "postal_code": "94560-4465", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0105-2018", "product_description": "FIFTY SHADES 6000 capsule, Proprietary Raw Material 4550, 1-capsule packets, distributed by Express Pac Trading, UPC 4026666146056", "product_quantity": "273 1-capsule packets", "reason_for_recall": "Marketed without an Approved NDA/ANDA: undeclared Active Pharmaceutical Ingredients sildenafil, desmethyl carbodenafil and tadalafil.", "recall_initiation_date": "20170915", "center_classification_date": "20171204", "termination_date": "20181204", "report_date": "20171213", "code_info": "All Lots", "more_code_info": ""}, {"status": "Terminated", "city": "South Beloit", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77732", "recalling_firm": "Precision Dose Inc.", "address_1": "722 Progressive Ln", "address_2": "N/A", "postal_code": "61080-2616", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "OH and CT", "recall_number": "D-1037-2017", "product_description": "Carbamazepine Oral Suspension, USP. 100 mg/5 mL, 5 mL Unit Dose Cups, Rx Only, Pkg: Precision Dose, Inc., S. Beloit, IL 61080, NDC 68094-301-59.", "product_quantity": "480 (5mL) unit dose cups", "reason_for_recall": "Labeling Error: Label mix-up.  Products' unit dose cups are correctly labeled, but the product carton lists incorrect volume and NDC.", "recall_initiation_date": "20170705", "center_classification_date": "20170731", "termination_date": "20180328", "report_date": "20170809", "code_info": "Lot #: 500326, Exp. 6/30/2018"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77770", "recalling_firm": "SCA Pharmaceuticals", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1005-2017", "product_description": "BUPIVacaine HCl 0.1% PF (From 0.75%) in 0.9% Sodium Chloride, 250 mL Bag, Preservative Free (Waste From 250 mL Bag), Rx only, SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR 72205 --- NDC# 70004-0060-40", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; product has the potential to leak.", "recall_initiation_date": "20170714", "center_classification_date": "20170726", "termination_date": "20190501", "report_date": "20170802", "code_info": "Lots: 20170429@33 BUD: 7/28/2017, 20170503@23 BUD: 8/1/2017"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0586-2017", "product_description": "HYDROQUINONE CREAM in all strengths including: 4%, 5%, 6%, 7%, 8%,10%, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0408-2017", "product_description": "Tri 2 (PAP/PHEN/ATROPINE) NR Injectable, 30 mg/3 mg/0.3 mg/mL, a) 2 mL and b) 5 mL vials, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "a) 238 vials and b) 607 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     a) Known lot code: 05042016@19, 06142016@28, 07262016@34, 09072016@22    b) Known lot code: 04112016@8, 05232016@2, 06212016@21, 07012016@22, 09082016@31."}, {"status": "Terminated", "city": "Chandler", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78227", "recalling_firm": "Banner Pharmacy Services, LLC", "address_1": "7300 W Detroit St", "address_2": "N/A", "postal_code": "85226-2410", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the US", "recall_number": "D-0023-2018", "product_description": "OXYtocin 30 units added to 0.9% Sodium Chloride 500 mL bag, Rx Only,  Banner Health Compounding Pharmacy 7300 W Detroit St Chandler, AZ 95226, NDC 7025000101", "product_quantity": "24306 units", "reason_for_recall": "Lack of Assurance of Sterility.", "recall_initiation_date": "20171010", "center_classification_date": "20171023", "termination_date": "20180809", "report_date": "20171101", "code_info": "Lot#: 072017S4, Exp 11/16/2017;  072117S2, Exp 11/17/2017; 072417S2,  Exp 11/20/2017; 072717S5, Exp 11/23/2017;  072817S3, Exp 11/24/2017;  073117S3, Exp 11/27/2017; 080217S3, Exp 11/29/2017; 080317S3, Exp 11/30/2017; 080917S3, Exp 12/6/2017; 081117S4,  Exp 12/8/2017; 081717S3, Exp 12/14/2017;  081817S1, Exp 12/15/2017;  082217S3, Exp 12/19/2017;  082317S3, 082317S5, Exp 12/20/2017; 082417S3, Exp 12/21/2017; 082517S2, Exp 12/22/2017."}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0574-2017", "product_description": "TRI-BLEACHING CREAM (Retinoic Acid 0.05%, Hydroquinone 4%, Fluocinolone 0.01%), Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "Salt Lake City", "state": "UT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76951", "recalling_firm": "Isomeric Pharmacy Solution, LLC", "address_1": "2401 S Foothill Dr Ste D", "address_2": "N/A", "postal_code": "84109-1479", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0681-2017", "product_description": "Methylprednisolone Acetate 40 mg/mL, Lidocaine HCl 10 mg/mL, 10 mL Multi-Dose Vial For Injection, Rx Only, Isomeric Pharmacy Solutions, 2401 Foothill Drive, SLC, UT 84109, Part # 1010, barcode 3 70285 10101 4.", "product_quantity": "4,001 vials", "reason_for_recall": "Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.", "recall_initiation_date": "20170406", "center_classification_date": "20170426", "termination_date": "20170830", "report_date": "20170503", "code_info": "Lot #s: 09007, Exp 04/04/17; 09016, Exp 04/16/17; 09020, Exp 04/18/17; 09025, Exp 04/23/17; 10026, 10030, Exp 05/28/17; 11007, Exp 05/30/17; 11008, Exp 05/31/17; 11020, Exp 06/07/17; 11028, Exp 06/12/17; 11043, Exp 06/26/17."}, {"status": "Terminated", "city": "Piscataway", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA203834"], "brand_name": ["ACYCLOVIR"], "generic_name": ["ACYCLOVIR"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "product_ndc": ["31722-777", "31722-778"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ACYCLOVIR"], "rxcui": ["197311", "197313"], "spl_id": ["bf4dff3e-da07-2dcf-e053-2995a90ad606"], "spl_set_id": ["0910335b-6796-459f-b97e-d7ef5439a060"], "package_ndc": ["31722-777-01", "31722-777-05", "31722-778-01", "31722-778-05"], "is_original_packager": [true], "upc": ["0331722778015", "0331722777018"], "nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "unii": ["X4HES1O11F"]}, "product_type": "Drugs", "event_id": "77122", "recalling_firm": "Hetero USA Inc", "address_1": "1035 Centennial Ave", "address_2": "N/A", "postal_code": "08854-4124", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0897-2017", "product_description": "Acyclovir Tablets, USP, 800 mg, 100-count bottle, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, by Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India, NDC 31722-778-01", "product_quantity": "13,692 bottles", "reason_for_recall": "Presence of Foreign Substance:  human hair melded into tablet.", "recall_initiation_date": "20170427", "center_classification_date": "20170607", "termination_date": "20171213", "report_date": "20170614", "code_info": "Lot # ACY16075 Exp. 09/2018"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0527-2017", "product_description": "5-FLUOROURACIL IN VANICREAM, FLUOROURACIL in all strengths including 0.05%, 5% CREAM, FLUOROURACIL 4.9% IN CERAVE CREAM,   Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "Wichita", "state": "KS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77584", "recalling_firm": "Fagron Compounding Services LLC dba Fagron Sterile Services", "address_1": "8710 E 34th St N", "address_2": "N/A", "postal_code": "67226-2636", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0946-2017", "product_description": "Succinylcholine Chloride, 100 mg per 5mL, 20 mg per mL syringe.  IV Use Only. JCB Laboratories, 8710 E 34th St., N. Wichita, KS 67226 UPC 7335968405", "product_quantity": "1,056 5mL syringes", "reason_for_recall": "Lack Of Assurance Of Sterility: voluntary recall initiated by the commercial supplier", "recall_initiation_date": "20170619", "center_classification_date": "20170706", "termination_date": "20180612", "report_date": "20170712", "code_info": "Lot #: C274-000000331, BUD 08/30/2017; C274-000001274, BUD 09/07/2017; C274-000001326, BUD 09/14/2017"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {"brand_name": ["PREVIDENT"], "generic_name": ["SODIUM FLUORIDE"], "manufacturer_name": ["Colgate Oral Pharmaceuticals, Inc."], "product_ndc": ["0126-0016"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["DENTAL"], "substance_name": ["SODIUM FLUORIDE"], "rxcui": ["392038", "630194"], "spl_id": ["f4c2f476-bdd5-49d1-80f7-361be61e47e5"], "spl_set_id": ["d93ee76f-454b-40bf-9357-39a2ae3b6ccb"], "package_ndc": ["0126-0016-61", "3834110622"], "is_original_packager": [true], "upc": ["0301260016610"], "unii": ["8ZYQ1474W7"]}, "product_type": "Drugs", "event_id": "76516", "recalling_firm": "Colgate Palmolive Co", "address_1": "300 Park Ave", "address_2": "Attn: Anthony Cavaliere", "postal_code": "10022-7402", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0521-2017", "product_description": "PreviDent 5000 ppm, DRY MOUTH, 1.1% Sodium Fluoride, PRESCRIPTION STRENGTH TOOTHPASTE, SLS Free Formula, SOOTHING MINT, 3.4 FL OZ (100 mL), Colgate Oral Pharmaceuticals, Inc., New York, NY 10022 --- NDC 0126-0016-61, UPC 3834110622", "product_quantity": "14,656 bottles", "reason_for_recall": "Label Mix up; rear panel is incorrectly labeled with the PreviDent 5000 Enamel Protect rear panel.", "recall_initiation_date": "20170213", "center_classification_date": "20170315", "termination_date": "20170613", "report_date": "20170322", "code_info": "Lots:  6350US561G, 6350US562G, 6351US561G, 6351US562G"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77191", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0908-2017", "product_description": "Potassium PHOSphate in 0.5% Dextrose, 7.5 mMol in 100 mL, Service Code 2K5299, NDC# 61553-0299-48, Total Volume 100.00 mL incorrectly labeled as 150.00 mL, Rx Only, PharMEDium Services, LLC, 12620 W. Airport Blvd #130, Sugar Land, TX 74478", "product_quantity": "144 bags", "reason_for_recall": "Labeling: Not Elsewhere Classified: Incorrect volume printed on the product label.", "recall_initiation_date": "20170217", "center_classification_date": "20170612", "termination_date": "20170613", "report_date": "20170621", "code_info": "Lot Numbers:  170020074D, 4/3/2017; 170050071D, 4/6/2017; 170270036D, 4/30/2017"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77191", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0910-2017", "product_description": "Potassium PHOSphate added to 0.9% Sodium Chloride, 15 mMol 100 mL Bag, Service Code 2K5295, NDC# 61553-0295-48, Total Volume 100.00 mL incorrectly labeled as105.00 mL, Rx Only, PharMEDium Services, LLC, 12620 W. Airport Blvd #130, Sugar Land, TX 74478", "product_quantity": "912 bags", "reason_for_recall": "Labeling: Not Elsewhere Classified: Incorrect volume printed on the product label.", "recall_initiation_date": "20170217", "center_classification_date": "20170612", "termination_date": "20170613", "report_date": "20170621", "code_info": "Lot Numbers:  170050001D, 4/5/2017; 170040025D, 4/5/2017; 170060046D, 4/9/2017; 170090062D, 4/10/2017;  170110125S, 4/12/2017; 170170016S, 4/18/2017; 170200120S, 4/23/2017;   170380108S, 5/9/2017;"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0300-2017", "product_description": "Testosterone Cypionate in Sesame Oil, 200 mg/mL, (5 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "7,168 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.    Known lot codes (Exp Date): 05252016A (11/21/2016), 06272016B (12/24/2016), 07262016D (01/22/2017), 07182016H (01/14/2017), 07182016G (01/14/2017), 08252016C (02/21/2017), 08222016B (02/18/2017), 08102016A (02/06/2017), 09282016D (03/27/2017), 09222016E (03/21/2017), 09152016A (02/28/2017), 09062016B (02/28/2017), 10252016C (02/28/2017), 10042016E (04/02/2017)."}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0257-2017", "product_description": "GAC, L-Glutamine/L-Arginine/L-Carnitine 25 mg/100 mg/200 mg/mL (30 mL).  Tri-Coast Pharmacy.", "product_quantity": "114 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.     Known lot codes (Exp Date): 06172016A (12/14/2016), 08092016B (02/05/2014), 09262016A (03/25/2017), 10132016E (02/28/2017)."}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "8 vials total (6/10mL vials and 2/30 mL vials)", "code_info": "Lot # t01-20-2017@87, Exp 4/23/2017; t02-08-2017@99, Exp 4/30/2017; t02-21-2017@113, Exp 4/30/2017.", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "HYDROXO-B12 10ML PBF MDV 5MG/ML INJ, 5mg/mL, Rx only, 10 mL Glass/ Multiple Dose vial, Prepared by Key Compounding Pharmacy      HYDROXO-B12 30ML PBF MDV 5MG/ML INJ, 5mg/mL, RX only, 30 mL Glass/ Multiple Dose vial.", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0724-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Edmond", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77064", "recalling_firm": "Qualgen", "address_1": "14844 Bristol Park Blvd", "address_2": "N/A", "postal_code": "73013-1891", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0896-2017", "product_description": "Estradiol 6 mg pellet 99.5% Estradiol USP, .5% Stearic Acid NF in 1 count, 12 count, and 30 count bottles, Sterile Office Use Only, For Subcutaneous Use Only Rx Only, Manufactured by; Qualgen 14844 Bristol Park Blvd. Edmond, OK 73013 NDC: 69761-006-01.", "product_quantity": "4,815 pellets.", "reason_for_recall": "CGMP deviations- Lack of Quality Assurance", "recall_initiation_date": "20170419", "center_classification_date": "20170607", "termination_date": "20210924", "report_date": "20170614", "code_info": "Lot# C046; Exp. 03/15/18  Lot# C025; Exp. 08/23/17  Lot# B159; Exp. 12/28/17  Lot# B121; Exp. 10/10/17  Lot# B118; Exp. 10/17/17  Lot# B086; Exp. 08/29/17  Lot# B068; Exp. 07/11/17  Lot# B053; Exp. 06/14/17  Lot# B034; Exp. 04/26/17"}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots within expiry", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "Ondansetron HCl all strengths, all dosage forms and all packaging, Rx  Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0843-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Pine Brook", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "76664", "recalling_firm": "Alvogen, Inc", "address_1": "10 Bloomfield Ave Bldg B Ste 2", "address_2": "N/A", "postal_code": "07058-9743", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0634-2017", "product_description": "Adalat CC (nifedipine) Extended-Release Tablets, 60 mg, 100-count bottles, Rx Only, Manufactured for  Almatica Pharma Inc. Pine Brook, NJ 07058 USA, NDC 5242749501", "product_quantity": "N/A", "reason_for_recall": "Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib", "recall_initiation_date": "20170307", "center_classification_date": "20170404", "termination_date": "20171215", "report_date": "20170412", "code_info": "Lot #: BXCUE1A, Exp. 01/2019"}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "Nalbuphine all strengths, all dosage forms and all packaging, Rx  Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0797-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0334-2017", "product_description": "ULTRA-TEST in Grapeseed Oil (CYP 90%/PROP 10%) Injectable, 200 mg/mL, 8 mL vial, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "714 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known lot code: 03302016@5, 04202016@2, 05172016@5, 06082016@44, 06102016@6, 08042016@14"}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "50 mL", "code_info": "Lot # t02-20-2017@75, Exp 4/22/2017.", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "GSH/NAC INH 2ML PV 60/100MG/ML SOLN, Inhalation Solution, 60mg/100mg/mL, Rx only, 5mL Plastic/Single Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0766-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0385-2017", "product_description": "QUAD4 (PAP/PHEN/ALPROS/ATRO) 30 mg/3 mg/60 mcg/0.2 mg/mL Injectable, a) 2 mL and b) 5 mL vials, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "114 vials and b) 1,017 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     a) Known lot code: 04072016@8, 06272016@22, 09082016@29    b) Known lot code: 04142016@16, 04272016@8, 06102016@13, 07062016@29, 08052016@1."}, {"status": "Terminated", "city": "Cranbury", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "76819", "recalling_firm": "Sun Pharmaceutical Industries, Inc.", "address_1": "270 Prospect Plains Rd", "address_2": "N/A", "postal_code": "08512-3605", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0701-2017", "product_description": "Olanzapine Tablets, 10 mg, packaged in a) 30-count bottles (NDC 62756-554-83), b) 100-count bottles (NDC 62756-554-88), and c) 1000-count bottles (NDC 62756-554-18), Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389, 350 Gujarat, India, NDC 62756-551-18.", "product_quantity": "38,316 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: out of specification results for the related substances test parameter (impurities).", "recall_initiation_date": "20170322", "center_classification_date": "20170510", "termination_date": "20180711", "report_date": "20170517", "code_info": "Lot #: a) JKP1354A, Exp 03/17, JKP2746A, Exp 06/17, JKR5751A, Exp 04/18; b) JKP1355A, Exp 03/17, JKP2738A, JKP3145A, Exp 06/17, JKR5476A, Exp 04/18; c) JKP1353A, Exp 03/17, JKP3146A, JKP2746B, Exp 06/17"}, {"status": "Terminated", "city": "Rancho Cucamonga", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77988", "recalling_firm": "Amphastar Pharmaceuticals, Inc.", "address_1": "11570 6th St", "address_2": "N/A", "postal_code": "91730-6025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed throughout the United States", "recall_number": "D-1124-2017", "product_description": "Ketorolac Tromethamine Injection, USP 30 mg/mL, packaged in 1 mL single-dose vials, Rx only, Amphastar Pharmaceuticals, Inc., Rancho Cucamonga, CA 91730, NDC 0548-9021-00", "product_quantity": "637,810 vials", "reason_for_recall": "Crystallization: Particulate matter (Ketorolac Calcium Salt) was observed from several lots of retained samples.", "recall_initiation_date": "20170815", "center_classification_date": "20170829", "termination_date": "20190114", "report_date": "20170906", "code_info": "Lot # XI002A6, XI003A6, Exp 12/17; XI004G6, XI005G6, Exp 6/18; XI007H6, Exp 7/18; XI00816, XI00916, XI01016, XI01116, Exp 8/18; XI012J6, XI013J6, Exp 9/18; XI015K6,  Exp 10/18; XI016L6, Exp 11/18; XL018A7, XI019A7, Exp 12/18; XI020B7, XI021B7,  Exp 1/19; XI022C7, XI023C7, Exp 2/19; XI025D7, Exp 3/19."}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots within expiry", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "Rocuronium Bromide all strengths, all dosage forms and all packaging, Rx Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0835-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0399-2017", "product_description": "Testosterone Cypionate / Zinc Sulf in Grapeseed Oil Injectable, 200 mg/200 mcg/mL, 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "266 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known lot code: 04012016@2, 05052016@4, 06022016@13, 06102016@35, 07052016@6."}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA018016"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-0043", "0338-0049"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1807551", "1807552", "1807627", "1807630", "1807631", "1807632", "1807633", "1807634", "1807639"], "spl_id": ["6ab23768-efd2-4ff1-b336-0dda08dc56e1"], "spl_set_id": ["f55bd888-5e01-474d-871b-24654c070178"], "package_ndc": ["0338-0049-01", "0338-0049-02", "0338-0049-03", "0338-0049-04", "0338-0049-10", "0338-0049-41", "0338-0049-11", "0338-0049-31", "0338-0049-48", "0338-0049-18", "0338-0049-38", "0338-0043-03", "0338-0043-04"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "77676", "recalling_firm": "Baxter Healthcare Corporation", "address_1": "1 Baxter Pkwy", "address_2": "", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Puerto Rico and Saudi Arabia", "recall_number": "D-0973-2017", "product_description": "0.9% Sodium Chloride Injection, USP, 100 mL VIAFLEX  Container, Rx Only, Baxter Healthcare Corporation, Deerfield IL 60015 USA, Product Code: 2B1309, NDC: 0338-0049-38", "product_quantity": "295,200 bags", "reason_for_recall": "Lack of Assurance of Sterility: Bags have the potential to leak.", "recall_initiation_date": "20170706", "center_classification_date": "20170711", "termination_date": "20200429", "report_date": "20170719", "code_info": "Lots: P361501, P361667, and P361790, Exp 09/30/18", "more_code_info": ""}, {"status": "Terminated", "city": "Broomfield", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76077", "recalling_firm": "Sandoz Incorporated", "address_1": "2555 W Midway Blvd", "address_2": "N/A", "postal_code": "80020-1632", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS and OH.", "recall_number": "D-0236-2017", "product_description": "Nadolol Tablets, USP, 40mg, packaged in 1000-count bottle, Rx Only, Manufactured by Sandoz Inc., Princeton, NJ 08540,  NDC 0781-1182-10", "product_quantity": "96 bottles", "reason_for_recall": "Failed dissolution specification: recalled due to an out of specification dissolution result of 40% (Specification: NLT 80%)", "recall_initiation_date": "20161222", "center_classification_date": "20161227", "termination_date": "20170918", "report_date": "20170104", "code_info": "Lot GG1539"}, {"status": "Terminated", "city": "Sugar Land", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77634", "recalling_firm": "PharMedium Services, Llc", "address_1": "12620 W Airport Blvd Ste 130", "address_2": "N/A", "postal_code": "77478-6200", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0987-2017", "product_description": "Potassium PHOSphate in 0.9% Sodium Chloride Injection 15 mMol in a) 100 mL in 150 mL Intravia Bag Service Code 2K5295 NDC# 61553-295-48; b) 150 mL in 150 mL Intravia Bag Service Code 2K5292 NDC# 61553-292-01; c)  250 mL in 250 mL Intravia Bag Service Code 2K5282 NDC# 61553-282-11; d) 250 mL in 250 mL Intravia Bag with Additive Cap Service Code 2K5291 NDC# 61553-291-11, Rx Only PharMEDium Services, LLC 12620 W. Airport Blvd #130 Sugar Land, TX 77478 800-523-7749", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; media fill failure at manufacturer", "recall_initiation_date": "20170626", "center_classification_date": "20170714", "termination_date": "20200429", "report_date": "20170726", "code_info": "Lots: a) 171320006S Exp. 8/13/2017, 171320014D Exp. 8/13/2017,171360020D Exp. 8/15/2017, 171520063D Exp. 8/31/2017; b) 171280054D Exp. 8/7/2017, 171320002D Exp. 8/10/2017, 171370005S Exp. 8/15/2017, 171440016D Exp. 8/23/2017, 171450012D Exp. 8/24/2017, 171510059D Exp. 8/30/2017, 171560027D Exp. 9/4/2017; c) 171170014S Exp. 7/27/2017, 171210127S Exp. 7/31/2017, 171230071D Exp. 8/2/2017, 171240002D Exp. 8/3/2017, 171240004D Exp. 8/3/2017, 171240191S Exp. 8/3/2017, 171280041D Exp. 8/7/2017, 171290077D Exp. 8/8/2017, 171300076D Exp. 8/9/2017, 171310058D Exp. 8/10/2017, 171320059D Exp. 8/13/2017, 171320190S Exp. 8/13/2017, 171360062D Exp. 8/15/2017, 171360068D Exp. 8/15/2017, 171380076D Exp. 8/17/2017, 171390064D Exp. 8/20/2017, 171390065D Exp. 8/20/2017, 171500064D Exp. 8/29/2017, 171530101S Exp. 9/3/2017, 171570058D Exp. 9/5/2017; d) 171210005S Exp. 7/30/2017, 171230008D Exp. 8/2/2017, 171500072D Exp. 8/29/2017, 171560028D Exp. 9/4/2017"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0371-2017", "product_description": "MIC/BCOMP+CAR+ARG+CHR+LID 12.5 mg/25 mg/25 mg/25 mg/12.5 mg/0.2 mg/20 mg/mL Injectable, a) 10 mL and b) 30 mL vial, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "511 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known lot code: a) 04192016@7, 05132016@7, 07052016@19, 08102016@9 and b) 04262016@4, 05132016@9, 05192016@9, 05252016@25, 08122016@1."}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77780", "recalling_firm": "Cantrell Drug Company", "address_1": "7321 Cantrell Rd", "address_2": "N/A", "postal_code": "72207-4144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the US", "recall_number": "D-1069-2017", "product_description": "Succinylcholine Chloride Injection Solution 5 mL, 100 mg/5 mL (20 mg/mL) Single-Dose Syringe, Rx Only, Cantrell Drug Company 7321 Cantrell Rd. Little Rock, AR 72207 877-666-5222, NDC 52533-067-15", "product_quantity": "18015 syringes", "reason_for_recall": "Lack of Sterility Assurance.", "recall_initiation_date": "20170714", "center_classification_date": "20170809", "termination_date": "20200916", "report_date": "20170816", "code_info": "Lot #: 10076, BUD: 7/24/2017; 10106, BUD: 7/27/2017; 10145, BUD: 8/2/2017; 10220, BUD: 8/13/2017; 10298, BUD: 8/20/2017; 10400, BUD: 9/6/2017; 10446, BUD: 9/14/2017; 10548, BUD: 9/27/2017"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "78021", "recalling_firm": "Noven Pharmaceuticals, Inc.", "address_1": "11960 SW 144th St", "address_2": "N/A", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1170-2017", "product_description": "Daytrana (methylphenidate transdermal system) Delivers 20 mg over 9 hours (2.2 mg/hr) Rx Only Contains: 30 Patches  Manufactured for: Noven Therapeutics, LLC. Miami, FL 33186 By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC# 68968-5554-3", "product_quantity": "182,850 patches", "reason_for_recall": "Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.", "recall_initiation_date": "20170830", "center_classification_date": "20170918", "termination_date": "20200124", "report_date": "20170927", "code_info": "Lot: 80431 Exp. 08/17", "more_code_info": ""}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.", "address_2": "", "product_quantity": "4800 syringes", "code_info": "Lot: 3/3/17 1830 81861S, BUD 07/01/17; 3/27/17 0658 81861S, BUD 7/25/17", "center_classification_date": "20171220", "distribution_pattern": "Nationwide in the USA to hospitals and medical facilities.", "state": "TX", "product_description": "NitroGlycerin 1 mg/10 mL in 5% Dextrose Inj, USP QS 10mL (100 mcg per mL), 10 mL Sterile single dose syringe, packaged in 5 x 5 (TWENTY FIVE) syringes per box, Rx only, Advanced Pharma, 9265 Kirby Dr., Houston, TX  77054, NDC 15082-818-61.", "report_date": "20171227", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0116-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77503", "termination_date": "20190403", "more_code_info": "", "recall_initiation_date": "20170609", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0578-2017", "product_description": "VI PEEL (Sal Acid 2%, TCA 17%, Phenol 7%, Retinoic Acid 0.4%), Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots within expiry", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "Labetalol HCl  all strengths, all dosage forms and all packaging, Rx Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0836-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77061", "recalling_firm": "Teligent, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "TN", "recall_number": "D-0787-2017", "product_description": "Desoximetasone Ointment USP, 0.25%, 15 g tubes,  Rx Only, Teligent Pharma, Inc. Buena. New Jersey 08310    NDC 52565-030-15", "product_quantity": "3600 tubes", "reason_for_recall": "Superpotent Drug", "recall_initiation_date": "20170407", "center_classification_date": "20170518", "termination_date": "20180220", "report_date": "20170524", "code_info": "Lot #: 5760, Exp. 5/31/2018", "more_code_info": ""}, {"status": "Terminated", "city": "New Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77398", "recalling_firm": "Spectrum Laboratory Products, Inc.", "address_1": "755 and 769 Jersey Ave", "address_2": "N/A", "postal_code": "08901-3605", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0882-2017", "product_description": "Levonorgestrel, U.S.P. active pharmaceutical ingredient, packaged in 1 kg container, Rx only, Spectrum Chemical Mfg. Corp, Gardena, CA  90248, New Brunswick, NJ  08901, Product code L1229.", "product_quantity": "1 container", "reason_for_recall": "CGMP Deviations: these repackaged and redistributed products are being recalled due to a recall notice from the active pharmaceutical ingredient manufacturer for deviations from current Good Manufacturing Practices that were found during a recent FDA inspection.", "recall_initiation_date": "20170413", "center_classification_date": "20170602", "termination_date": "20190221", "report_date": "20170614", "code_info": "Lot #: 2FD0376, Exp 02/21/21"}, {"status": "Terminated", "city": "Peapack", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "76663", "recalling_firm": "Pfizer Inc", "address_1": "100 North Route 206", "address_2": "", "postal_code": "07977", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within US", "recall_number": "D-0607-2017", "product_description": "Quillivant XR (methylphenidate HCl) for extended-release oral suspension, 300 mg/60 mL (25mg/5mL), Rx Only, Distributed by: NextWave Pharmaceuticals, Inc. A subsidiary of Pfizer Inc, New York, NY 10017  Manufactured by: Tris Pharma, Inc., Monmouth Junction, NJ 08852 (NDC 24478-190-10).", "product_quantity": "28,938  units", "reason_for_recall": "Failed Dissolution Specifications: Dissolution at 8 hour was out of specification at 12 month at 25 degree Celsius.", "recall_initiation_date": "20170307", "center_classification_date": "20170322", "termination_date": "20190531", "report_date": "20170329", "code_info": "Lot #: 03215042A, Exp. 08/17.", "more_code_info": ""}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0379-2017", "product_description": "Mitomycin 20 mg  Injectable, Lyophilized (Buffered), 1 mL vial, Kit, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "315 kits (number of vials per kit vary by prescription)", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known kit lot code: 05122016@84, 07012016@107.  Known vial lot code: 04212016@149, 06082016@7."}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77936", "recalling_firm": "MEDLINE INDUSTRIES INC", "address_1": "3 Lakes Dr", "address_2": "N/A", "postal_code": "60093-2753", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1138-2017", "product_description": "Vitamin A&D Ointment (petroleum 93.5%), Skin Protectant, NET Wt. 0.18 OZ (5g),  Manufactured for Medline Industries, Inc., Northfield, IL 60093 USA.  NDC: 53329-090-16", "product_quantity": "462 cases, 144 packets per case", "reason_for_recall": "Labeling Mixup; the individual A&D ointment foil packets are incorrectly labeled as petroleum jelly. The boxes and outer case are correctly labeled as A&D ointment.", "recall_initiation_date": "20170803", "center_classification_date": "20170912", "termination_date": "20171121", "report_date": "20170920", "code_info": "Lot Number: A-K-8383"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0282-2017", "product_description": "Quad Mix, Alprostadil/Phentolamine/Papaverine/Atropine 10mcg/3mg/30mg/200mg/ml, (1 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "10 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.     Known lot codes (Exp Date): 10262016H (12/09/2016), 11032016C (12/09/2016)."}, {"status": "Terminated", "city": "Chicago", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77357", "recalling_firm": "Global Marketing Enterprises, Inc.", "address_1": "1801 S Canal St", "address_2": "N/A", "postal_code": "60616-1522", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "KY, VA, MI", "recall_number": "D-1096-2017", "product_description": "Caffeine Powder, Anhydrous, Pharmaceutical Grade, 100% Pure caffeine, 250 g (8.8 oz)., 1250 servings, Packed By:  LifeLine Nutrients Corp, 1801 S. Canal St, Chicago, IL 60616, UPC 021754905076", "product_quantity": "52.5 kg", "reason_for_recall": "Marketed without an Approved NDA/ANDA:  The product consists of pure, powdered caffeine and is an unapproved drug due to stimulant claims.  The product is also misbranded as it fails to bear adequate directions for its intended use.", "recall_initiation_date": "20170522", "center_classification_date": "20170817", "termination_date": "20220825", "report_date": "20170823", "code_info": "Batch # 15121931, 15121939, Exp 12/19"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA202099"], "brand_name": ["ZENATANE"], "generic_name": ["ISOTRETINOIN"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-113", "55111-135", "55111-136", "55111-137"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ISOTRETINOIN"], "rxcui": ["197843", "197844", "197845", "403930", "1373333", "1373335", "1373337", "1605088"], "spl_id": ["d7d883f9-7d20-2c50-8023-e661b46dcd5b"], "spl_set_id": ["27b3cf26-f22e-5b70-1c24-009933b7c6ee"], "package_ndc": ["55111-135-79", "55111-135-81", "55111-136-79", "55111-136-81", "55111-137-79", "55111-137-81", "55111-113-79", "55111-113-81", "55111-113-78"], "is_original_packager": [true], "nui": ["N0000175607", "M0018962"], "pharm_class_epc": ["Retinoid [EPC]"], "pharm_class_cs": ["Retinoids [CS]"], "unii": ["EH28UP18IF"]}, "product_type": "Drugs", "event_id": "76539", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0506-2017", "product_description": "Zenatane (isotretinoin) capsules, 40 mg, packaged in 30-count  cartons (3 x 10 blister cards), Rx Only, Manufactured By: Cipla Limited Kurkumbh Village Pune 413802 India, Manufactured For: Dr. Reddy's Laboratories, Bachupally 500 090  India,NDC 55111-137-81", "product_quantity": "4032 cartons", "reason_for_recall": "Failed dissolution specifications - low dissolution  results at S3 stage.", "recall_initiation_date": "20170215", "center_classification_date": "20170302", "termination_date": "20181219", "report_date": "20170308", "code_info": "Lot # 01KB60250, Exp 3/18", "more_code_info": ""}, {"country": "United States", "city": "Raymondville", "address_1": "910 E Hidalgo Ave", "reason_for_recall": "CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.", "address_2": "Suite 3", "product_quantity": "24 bottles", "code_info": "Lot: 23221701, Exp. 05/19", "center_classification_date": "20170911", "distribution_pattern": "TX", "state": "TX", "product_description": "Doctor Manzanilla Cough & Cold (diphenhydramine hydrochloride and phenylephrine hydrochloride) Syrup, 12.5 mg and 5 mg in each 5 mL, 4 fl oz. (118 mL) bottle, Distributed by: Midvalley Pharmaceuticals, Raymondville, TX  78580, UPC 7 62558 00316 1.", "report_date": "20170920", "classification": "Class II", "openfda": {}, "recalling_firm": "Mid Valley Pharmaceutical", "recall_number": "D-1136-2017", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "78049", "termination_date": "20200507", "recall_initiation_date": "20170830", "postal_code": "78580-4095", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0316-2017", "product_description": "TriMix, Alprostadil/Phentolamine/Papaverine 30mcg/0.5mg/10mg/mL, (1 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "13 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.    Known lot codes (Exp Date): 06282016A (08/04/2016), 06222016C (08/04/2016), 07182016D (09/01/2016), 11102016D (12/09/2016), 10202016B (11/24/2016)."}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots within expiry", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "Heparin sodium all strengths, all dosage forms and all packaging, Rx  Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0822-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Richmond", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78174", "recalling_firm": "Deserving Health International Corp", "address_1": "13160 Vanier Pl Unit 110", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States.", "recall_number": "D-0011-2018", "product_description": "Symbio Muc Eye, 0.17 fl.oz. 5mL bottles, Manufactured for and distributed in the US b: Biological Health Group Corp. Bremerton, WA 98337. NDC 69711-125-61", "product_quantity": "623 dropper bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20170920", "center_classification_date": "20171018", "termination_date": "20190124", "report_date": "20171025", "code_info": "Lot #: DM17B12, Exp 03/2020; DM16L44, Exp 12/2019;   DM16L07, Exp12/2019", "more_code_info": ""}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0291-2017", "product_description": "Sermorelin Forte 12 mg (Sermorelin Acetate 6 mg/GHRP-6 6 mg). Compounded by Tri-Coast Pharmacy", "product_quantity": "188 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.    Known lot codes (Exp Date): 06152016C (12/12/2016), 10242016C (04/22/2017)."}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "180mL", "code_info": "Lot # t02-21-2017@111, Exp 4/23/2017", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "GSH/NAC INH PV 150/50MG/ML SOLN, Inhalation Solution, 150mg/50mg/mL, Rx only, 4mL Plastic/Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0767-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0278-2017", "product_description": "Nandrolone Decanoate 200 mg/ml, (5 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "701 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.     Known lot codes (Exp Date): 07112016A (12/31/2016), 08172016B (2/13/2017), 09122016C (02/28/2017), 10252016E (02/28/2017)."}]